Government in the Sunshine Act Meeting Notice; Change of Time of Commission Meeting, 20000 [2010-8852]

Download as PDF 20000 Federal Register / Vol. 75, No. 73 / Friday, April 16, 2010 / Notices SUMMARY: This order extends the withdrawal created by Public Land Order No. 6776 for an additional 20-year period. This extension is necessary to continue protection of the North Cascades Scenic Highway Zone in Chelan, Okanogan, Skagit, and Whatcom Counties, Washington which would otherwise expire on April 17, 2010. DATES: Effective Date: April 18, 2010. FOR FURTHER INFORMATION CONTACT: Gregory B. Graham, U.S. Forest Service Okanogan-Wenatchee National Forest, 215 Melody Lane, Wenatchee, Washington 98801, (509) 664–9262, or Charles R. Roy, Bureau of Land Management Oregon/Washington State Office, P.O. Box 2965, Portland, Oregon 97208, (503) 808–6189. SUPPLEMENTARY INFORMATION: The purpose for which the withdrawal was first made requires this extension to continue protection of the unique natural, scenic, and recreational values and the investment of Federal funds along the North Cascades Scenic Highway Zone within the Mt. Baker, Okanogan, and Wenatchee National Forest. The United States Forest Service will continue to manage the lands to protect these values. Order By virtue of the authority vested in the Secretary of the Interior by Section 204 of the Federal Land Policy and Management Act of 1976, 43 U.S.C. 1714, it is ordered as follows: 1. Public Land Order No. 6776 (55 FR 14422, (1990)) that withdrew 8,950 acres of National Forest System lands from location or entry under the United States mining laws (30 U.S.C. ch. 2) on behalf of the Forest Service to protect the North Cascades Scenic Highway Zone, is hereby extended for an additional 20-year period. 2. Public Land Order No. 6776 will expire on April 17, 2030, unless, as a result of a review conducted prior to the expiration date, pursuant to Section 204(f) of the Federal Land Policy Management Act of 1976, 43 U.S.C. 1714(f), the Secretary of the Interior determines that the withdrawal shall be extended. Dated: April 9, 2010. Wilma A. Lewis, Assistant Secretary—Land and Minerals Management. [FR Doc. 2010–8778 Filed 4–15–10; 8:45 am] BILLING CODE 3410–11–P INTERNATIONAL TRADE COMMISSION [USITC SE–10–011] Government in the Sunshine Act Meeting Notice; Change of Time of Commission Meeting United States International Trade Commission. ORIGINAL DATE AND TIME: April 15, 2010 at 11 a.m. NEW DATE AND TIME: April 15, 2010 at 2:30 p.m. PLACE: Room 101, 500 E Street SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. In accordance with 19 CFR 201.37(a), the Commission has determined to AGENCY HOLDING THE MEETING: reschedule the above referenced Commission meeting from 11 a.m. to 2:30 p.m. on April 15, 2010. Earlier announcement of this rescheduling was not possible. Issued: April 13, 2010. By order of the Commission. William R. Bishop, Hearings and Meetings Coordinator. [FR Doc. 2010–8852 Filed 4–14–10; 11:15 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with Title 21 Code of Federal Regulations (CFR), 1301.34(a), this is notice that on February 15, 2010, Lipomed, Inc., One Broadway, Cambridge, Massachusetts 02142, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: WReier-Aviles on DSKGBLS3C1PROD with NOTICES Drug Schedule Cathinone (1235) ......................................................................................................................................................................................... Methcathinone (1237) .................................................................................................................................................................................. N-Ethylamphetamine (1475) ........................................................................................................................................................................ Fenethylline (1503) ...................................................................................................................................................................................... Methaqualone (2565) .................................................................................................................................................................................. Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... Lysergic acid diethylamide (7315) ............................................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... Marihuana (7360) ........................................................................................................................................................................................ Tetrahydrocannabinols (7370) ..................................................................................................................................................................... Mescaline (7381) ......................................................................................................................................................................................... 3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ 4–Bromo-2,5-dimethoxyamphetamine (7391) ............................................................................................................................................. 4–Bromo-2,5-dimethoxyphenethylamine (7392) ......................................................................................................................................... 4–Methyl-2,5-dimethoxyamphetamine (7395) ............................................................................................................................................. 2,5–Dimethoxyamphetamine (7396) ........................................................................................................................................................... 2,5–Dimethoxy-4-ethylamphetamine (7399) ............................................................................................................................................... 3,4–Methylenedioxyamphetamine (7400) ................................................................................................................................................... 3,4–Methylenedioxy-N-ethylamphetamine (7404) ....................................................................................................................................... 3,4–Methylenedioxymethamphetamine (7405) ........................................................................................................................................... 4–Methoxyamphetamine (7411) .................................................................................................................................................................. Dimethyltryptamine (7435) .......................................................................................................................................................................... Psilocybin (7437) ......................................................................................................................................................................................... Psilocyn (7438) ............................................................................................................................................................................................ N–Benzylpiperazine (7493) ......................................................................................................................................................................... VerDate Nov<24>2008 15:07 Apr 15, 2010 Jkt 220001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\16APN1.SGM 16APN1 I I I I I I I I I I I I I I I I I I I I I I I I I

Agencies

[Federal Register Volume 75, Number 73 (Friday, April 16, 2010)]
[Notices]
[Page 20000]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8852]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-10-011]


Government in the Sunshine Act Meeting Notice; Change of Time of 
Commission Meeting

Agency Holding the Meeting:  United States International Trade 
Commission.

Original Date and Time:  April 15, 2010 at 11 a.m.

New Date and Time:  April 15, 2010 at 2:30 p.m.

Place:  Room 101, 500 E Street SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

Status:  Open to the public.
    In accordance with 19 CFR 201.37(a), the Commission has determined 
to reschedule the above referenced Commission meeting from 11 a.m. to 
2:30 p.m. on April 15, 2010. Earlier announcement of this rescheduling 
was not possible.

    Issued: April 13, 2010.

    By order of the Commission.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. 2010-8852 Filed 4-14-10; 11:15 am]
BILLING CODE 7020-02-P